Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
BANNOCKBURN, Ill. , Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended
Toggle Summary Option Care Health Selected as a Limited Distribution Provider of VILTEPSO™ (viltolarsen) Injection for Patients with Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
BANNOCKBURN, Ill. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has been selected to participate in the limited distribution network of VILTEPSO™
Toggle Summary Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy
First surgery-free treatment option for rare, difficult-to-treat urinary tract cancer requires complex clinical protocol BANNOCKBURN, Ill. , May 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent provider
Toggle Summary Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment
National leader in treating bleeding disorders offers personalized, high-quality patient care BANNOCKBURN, Ill. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. , the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been chosen by
Toggle Summary Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill. , May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc.
Toggle Summary Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation
DENVER & BANNOCKBURN, Ill. --(BUSINESS WIRE)--Jan. 8, 2024-- Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services,
Toggle Summary Option Care Health to Announce First Quarter 2020 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , April 16, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that it will release results for its first quarter ended March 31,
Toggle Summary Option Care Health to Announce First Quarter 2021 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , April 15, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended
Toggle Summary Option Care Health to Announce First Quarter 2022 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , April 07, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended
Toggle Summary Option Care Health to Announce First Quarter 2023 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31,